Vastra Frolunda, Sweden

Ruth Elvy Bylund


Average Co-Inventor Count = 2.9

ph-index = 8

Forward Citations = 126(Granted Patents)


Location History:

  • V astra Fr olunda, SE (1997 - 1999)
  • Västra Frölunda, SE (2006)

Company Filing History:


Years Active: 1997-2006

Loading Chart...
11 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Ruth Elvy Bylund

Introduction: Ruth Elvy Bylund, a prominent inventor based in Vastra Frolunda, Sweden, has made significant contributions to the field of pharmaceuticals with a total of 11 patents to her name. Her innovative approaches to medical treatment have helped advance the understanding and application of drug development.

Latest Patents: Among Bylund’s latest patents are her groundbreaking work on peptide derivatives, which includes a pharmaceutical preparation that contains an effective amount of acetylsalicylic acid combined with a compound of Formula I. Additionally, she has developed a method of thrombin inhibition, focusing on treating or preventing thrombosis and hypercoagulability through the use of specific compounds and their stereoisomers.

Career Highlights: Throughout her career, Bylund has worked with some notable companies in the pharmaceutical industry, including Astra Aktiebolag and Aktiebolaget Astra. Her work within these organizations has allowed her to contribute critically to the advancement of medicinal chemistry and innovative treatments.

Collaborations: Ruth has collaborated with esteemed colleagues such as Karl Thomas Antonsson and Nils David Gustafsson. These collaborations have fostered innovation and enabled Bylund to push the boundaries of scientific discovery, leading to breakthrough inventions in her field.

Conclusion: Ruth Elvy Bylund stands as a remarkable figure in pharmaceutical innovation, with a portfolio of patents that reflect her dedication to medical advancement. Her contributions continue to influence the industry and inspire future generations of inventors and scientists.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…